Citi analyst Joanne Wuensch lowered the firm’s price target on Insulet to $273 from $319 and keeps a Neutral rating on the shares post the Q2 report. The analyst says tough compares and a GLP-1 “overhang on an expensive stock” keeps it on the sidelines.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PODD: